Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The M&A Healthcare Insights Podcast: Interview With Haran Narulla

Figuring out where to put your money isn’t always easy, but for one man, it’s his main job. M&A Healthcare experts and hosts Mike Moran, Co-Founder, Executive Advisor, and Co-Founder Mark Thomas, chatted with Haran Narulla, Managing Partner at Tygon Peak Capital, about the current acquisition market and his everyday strategies. Moran reflected on…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Figuring out where to put your money isn’t always easy, but for one man, it’s his main job. M&A Healthcare experts and hosts Mike Moran, Co-Founder, Executive Advisor, and Co-Founder Mark Thomas, chatted with Haran Narulla, Managing Partner at Tygon Peak Capital, about the current acquisition market and his everyday strategies.

Moran reflected on building a relationship with Narulla, “The reality of our business model, right, is that we represent sellers…along the way, for better or worse, you build relationships…and those relationships are with buyers.”

As a capital investment firm, Tygon Peak has to be specific in its needs. Narulla said, “We basically focus on three different verticals, one is healthcare, the second is mixed manufacturing, and the third is business services.”

When assessing an asset for acquisition, Narulla explained that he looks at three key subjects: industry, risks, and quality. Narulla said, “Our number one target industry today is healthcare.” This means that in assessing, he looks toward home health, urgent care, and medical practices. Then they rely on relevant facts for the industry to better understand the risks and opportunities in the current market. After which, he will look at the quality of the asset itself, whether it has a large or small market share and what level of experience the management team carries.

As for research, Narulla stated, “There’s some sectors where we’ve done quite a lot of work, and we understand what’s going on in those specific segments, and some of the segments we’ve done less work and so we do a fair amount of work, you know, after.”

Given the challenges in the labor market, Narulla stated that finding managers to come and run a business has been more difficult than years previously, although there are certainly still options. He said, “I think you have to provide them with a compelling reason to come work for you.” Whether this compulsion is in compensation or project ideas is up to negotiation. In any case, Narulla reflected that Tygon’s acquisition strategy has constantly had to adjust to reflect the current market and prepare for future market indexes.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512